910616-72-7 Usage
Uses
Used in Organic Synthesis:
3-Chloro-2-iodo-5,6-diMethoxy-pyridine is used as a building block in organic synthesis for the creation of more complex molecules. Its unique structure and reactivity make it a valuable tool in this field.
Used in Pharmaceutical Research:
In pharmaceutical research, 3-Chloro-2-iodo-5,6-diMethoxy-pyridine is utilized as a key intermediate in the development of new drugs. Its diverse properties contribute to the design and synthesis of innovative pharmaceutical compounds.
Used in Agrochemicals:
3-Chloro-2-iodo-5,6-diMethoxy-pyridine is used in the field of agrochemicals due to its potential applications in the development of new agrochemical products, leveraging its versatile chemical properties.
Used in Fine Chemicals:
3-Chloro-2-iodo-5,6-diMethoxy-pyridine also finds use in the fine chemicals industry, where its diverse properties are harnessed for the production of specialty chemicals that require specific structural features.
Safety Precautions:
When handling 3-Chloro-2-iodo-5,6-diMethoxy-pyridine, it is important to take safety precautions, as it may pose health hazards if not used properly. Proper handling, storage, and disposal methods should be followed to minimize risks.
Check Digit Verification of cas no
The CAS Registry Mumber 910616-72-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,0,6,1 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 910616-72:
(8*9)+(7*1)+(6*0)+(5*6)+(4*1)+(3*6)+(2*7)+(1*2)=147
147 % 10 = 7
So 910616-72-7 is a valid CAS Registry Number.
910616-72-7Relevant articles and documents
ISOXAZOLOPYRIDINE OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 40, (2013/05/21)
The present invention is directed to isoxazolopyndine compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the isoxazolopyndine compounds described herein in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.